AREV Life Sciences Global Corp.

OTCPK:AREV.F Stock Report

Market Cap: US$2.0m

AREV Life Sciences Global Management

Management criteria checks 2/4

AREV Life Sciences Global's CEO is Mike Withrow, appointed in Oct 2018, has a tenure of 6.17 years. directly owns 43.44% of the company’s shares, worth $863.36K. The average tenure of the management team and the board of directors is 5 years and 3.7 years respectively.

Key information

Mike Withrow

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.2yrs
CEO ownership43.4%
Management average tenure5yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mike Withrow's remuneration changed compared to AREV Life Sciences Global's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-CA$240k

Jun 30 2023n/an/a

-CA$451k

Mar 31 2023n/an/a

-CA$1m

Dec 31 2022CA$167kCA$167k

-CA$1m

Compensation vs Market: Insufficient data to establish whether Mike's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Mike's compensation with company performance.

CEO

Mike Withrow (61 yo)

6.2yrs

Tenure

CA$166,891

Compensation

Mr. Michael C. Withrow, also known as Mike, is the founder of the AREV Life Sciences Global Corp. and has been its Chairman of the Board since November 13, 2016 and has been its Chief Executive Officer sin...

Leadership Team

NamePositionTenureCompensationOwnership
Michael Withrow
Chairman & CEO6.2yrsCA$166.89k43.44%
$ 863.4k
Denby Greenslade
Interim CFO5yrsCA$72.00k1.15%
$ 22.9k
Donald Shaxon
Vice President of Marketing4yrsno datano data

5.0yrs

Average Tenure

Experienced Management: AREV.F's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael Withrow
Chairman & CEO8.1yrsCA$166.89k43.44%
$ 863.4k
Denby Greenslade
Interim CFO5yrsCA$72.00k1.15%
$ 22.9k
Kevin Phelps
Independent Director3.8yrsCA$103.33kno data
Harold Smith
Member of Scientific Advisory Board3.5yrsno datano data
Roscoe Moore
Chairman of Scientific Advisory Board3.8yrsno datano data
Douglas Sorocco
Member of Scientific Advisory Board2.8yrsno datano data
Uma V. Dhanabalan
Member of Scientific Advisory Board3.8yrsno datano data
Jay Noller
Member of Scientific Advisory Board3.8yrsno datano data
Richard Van Breemen
Member of Scientific Advisory Board3.4yrsno datano data
Allan Echino
Independent Director3yrsno data2.42%
$ 48.1k
Brian Elliott
Independent Director2.8yrsno datano data
Sateesh Apte
Member of Scientific Advisory Board2.3yrsno datano data

3.7yrs

Average Tenure

69yo

Average Age

Experienced Board: AREV.F's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 05:07
End of Day Share Price 2024/10/30 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AREV Life Sciences Global Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution